Untreated Adult Acute Lymphoblastic Leukemia Completed Phase 1 Trials for Imatinib (DB00619)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | Treatment |